Vireo Growth (VREOF) Acquisitions (2025 - 2026)

Vireo Growth's (VREOF) quarterly Acquisitions came in at -$18.2 million in Q1 2026, down 47.29% quarter-over-quarter from -$12.4 million in Q4 2025.

Vireo Growth (VREOF) Acquisitions (2025 - 2026) Analysis & Trends

Vireo Growth has disclosed Acquisitions across 2 years of filings, most recently posting -$18.2 million for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	2.09 Bn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	137.87 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Vireo Growth	-	-	59.30 Mn	-18.20 Mn

Download Data